GSK2894631A is a hematopoietic PGD synthase (HPGDS) inhibitor.
For research use only. We do not sell to patients.
| Name | GSK2894631A |
|---|---|
| Iupac Chemical Name | 7-(Difluoromethoxy)-N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexyl]-3-quinolinecarboxamide |
| Synonyms | GSK2894631A; GSK-2894631A; GSK 2894631A; GSK2894631; GSK-2894631; GSK 2894631; |
| Molecular Formula | C20H24F2N2O3 |
| Molecular Weight | 378.4198 |
| Smile | O=C(C1=CC2=CC=C(OC(F)F)C=C2N=C1)N[C@H]3CC[C@H](C(C)(O)C)CC3 |
| InChiKey | YRWMWDLEUYLURJ-SHTZXODSSA-N |
| InChi | InChI=1S/C20H24F2N2O3/c1-20(2,26)14-4-6-15(7-5-14)24-18(25)13-9-12-3-8-16(27-19(21)22)10-17(12)23-11-13/h3,8-11,14-15,19,26H,4-7H2,1-2H3,(H,24,25)/t14-,15- |
| CAS Number | 2101626-26-8 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% Min. |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Sarver DC, Sugg KB, Talarek JR, et al. Prostaglandin D2 signaling is not involved in the recovery of rat hind limb tendons from injury. Physiol Rep. 2019;7(22):e14289. doi:10.14814/phy2.14289